Myriad Genetics Inc (NASDAQ:MYGN)

27.37
Delayed Data
As of May 14
 +1.69 / +6.58%
Today’s Change
10.54
Today|||52-Week Range
33.97
+38.41%
Year-to-Date

Today’s Trading

Previous close25.68
Today’s open25.89
Day’s range25.74 - 27.39
Volume12,551
Average volume (3 months)743,981
Market cap$2.1B
Data as of 3:59pm ET, 05/14/2021

Growth & Valuation

Earnings growth (last year)-4,389.30%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-24.97%
P/E ratioNM
Price/Sales1.32
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.35+1.69%
VCYTVeracyte Inc+1.41+4.01%
CLDXCelldex Therapeutics...+2.02+8.08%
TRILTrillium Therapeutic...+0.20+2.31%
Data as of 4:00pm ET, 05/14/2021

Financials

Next reporting dateSeptember 1, 2021
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$638.6M
Annual profit (last year)-$199.5M
Net profit margin-31.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts